Literature DB >> 15664140

The influence of excipients on the diffusion of ibuprofen and paracetamol in gastric mucus.

Lance R Shaw1, William J Irwin, Tim J Grattan, Barbara R Conway.   

Abstract

The aim of this study was to examine the diffusion of commonly administered analgesics, ibuprofen and paracetamol, through gastric mucus. As ibuprofen and paracetamol are often formulated with alkalising excipients, or are commonly co-administered with antacids that have been demonstrated to alter their absorption, diffusion was also studied in the presence of a range of soluble and insoluble antacids or buffering agents. The effect of pH, which has been demonstrated to modify the properties of mucus, was also studied. Mucus was a significant barrier to diffusion for both drugs, compared to an unstirred aqueous layer with diffusion rates significantly lower in the presence of a mucus barrier for both drugs; ibuprofen diffusion also demonstrated a significant increase in the lag time. Paracetamol diffusion was not significantly affected by addition of any antacid, whereas ibuprofen rates were affected and the diffusion lag time for ibuprofen was significantly reduced in all cases. Isolated increases in pH increased the rate and reduced the lag time for ibuprofen diffusion. It was shown that mucus acts as a passive barrier in the case of paracetamol diffusion, and an interactive barrier to ibuprofen diffusion. Changes in mucus viscosity at different pH values may be responsible for the observed changes in ibuprofen diffusion rate.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15664140     DOI: 10.1016/j.ijpharm.2004.11.028

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  6 in total

1.  Development of 2D and 3D mucus models and their interactions with mucus-penetrating paclitaxel-loaded lipid nanocapsules.

Authors:  Anne-Claire Groo; Kristina Mircheva; Jérôme Bejaud; Caroline Ailhas; Ivan Panaiotov; Patrick Saulnier; Tzvetanka Ivanova; Frederic Lagarce
Journal:  Pharm Res       Date:  2014-01-28       Impact factor: 4.200

2.  Influence of the nanocomposite MgAl-HTlc on gastric absorption of drugs: in vitro and ex vivo studies.

Authors:  Luana Perioli; Pamela Mutascio; Cinzia Pagano
Journal:  Pharm Res       Date:  2012-08-23       Impact factor: 4.200

3.  Fabrication and Evaluation of Bi-layer Tablet Containing Conventional Paracetamol and Modified Release Diclofenac Sodium.

Authors:  M C Gohel; R K Parikh; S A Nagori; B A Jethwa
Journal:  Indian J Pharm Sci       Date:  2010-03       Impact factor: 0.975

Review 4.  Mucins reprogram stemness, metabolism and promote chemoresistance during cancer progression.

Authors:  Saravanakumar Marimuthu; Sanchita Rauth; Koelina Ganguly; Chunmeng Zhang; Imayavaramban Lakshmanan; Surinder K Batra; Moorthy P Ponnusamy
Journal:  Cancer Metastasis Rev       Date:  2021-04-04       Impact factor: 9.237

5.  Fate of paclitaxel lipid nanocapsules in intestinal mucus in view of their oral delivery.

Authors:  Anne-Claire Groo; Patrick Saulnier; Jean-Christophe Gimel; Julien Gravier; Caroline Ailhas; Jean-Pierre Benoit; Frederic Lagarce
Journal:  Int J Nanomedicine       Date:  2013-11-07

6.  Formulation and pharmacokinetics of multi-layered matrix tablets: Biphasic delivery of diclofenac.

Authors:  Ehab Mostafa Elzayat; Ali Abdelzaher Abdel-Rahman; Sayed Mohamed Ahmed; Fars Kaed Alanazi; Walid Abdulazim Habib; Hisham Suliman Abou-Auda; Adel Sakr
Journal:  Saudi Pharm J       Date:  2016-10-17       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.